|
Gene polymorphism profile may predict invasive aspergillosis development in patients with acute leukaemias undergoing allogeneic stem cell transplantation (click for details) |
|
|
|
Prospective surveillance for invasive fungal infection in allogeneic haematopoietic stem cell transplant (HCT): epidemiology, risk factors and outcome in a single centre (click for details) |
|
|
|
Results of antimycotic prophylaxis with posaconazole in patients with severe graft-versus-host disease (GVHD): a single centre analysis (click for details) |
|
|
|
Changing face of invasive Aspergillus infections in children undergoing haematopoietic stem cell transplantation: a single centre observational study over 20 years (click for details) |
|
|
|
Clinical evaluation of secondary posaconazole prophylaxis in the initial neutropenic phase of allo-HSCT: a small case series from a single unit (click for details) |
|
|
|
Randomized trial of prophylaxis with intravenous micafungin during haematopoietic stem cell transplantation (click for details) |
|
|
|
Clinical efficacy and management of primary antifungal prophylaxis with posaconazole in high-risk haematology patients (click for details) |
|
|
|
Efficacy and safety of micafungin for prophylaxis of invasive fungal infections in patients undergoing haploidentical haematopoietic stem cell transplant (click for details) |
|
|
|
Fungal colonization, emergence of resistant strains, and breakthrough invasive fungal infections during antifungal prophylaxis with micafungin in patients with leukaemia and stem cell transplant recipients. A retrospective single centre analysis (click for details) |
|
|
|
A survey of infectious disease clinical practices among paediatric blood and marrow transplant programmes in the United States (click for details) |
|
|
